JPS6365646B2 - - Google Patents

Info

Publication number
JPS6365646B2
JPS6365646B2 JP54101211A JP10121179A JPS6365646B2 JP S6365646 B2 JPS6365646 B2 JP S6365646B2 JP 54101211 A JP54101211 A JP 54101211A JP 10121179 A JP10121179 A JP 10121179A JP S6365646 B2 JPS6365646 B2 JP S6365646B2
Authority
JP
Japan
Prior art keywords
concentration
capsule
present
derivatives
dihydroxycholecalciferol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54101211A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5626820A (en
Inventor
Tadao Aoki
Hideo Myakoshi
Yoshihei Hirasawa
Yasuho Nishii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP10121179A priority Critical patent/JPS5626820A/ja
Priority to US06/176,642 priority patent/US4341774A/en
Publication of JPS5626820A publication Critical patent/JPS5626820A/ja
Publication of JPS6365646B2 publication Critical patent/JPS6365646B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10121179A 1979-08-10 1979-08-10 Immunosuppressing agent Granted JPS5626820A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP10121179A JPS5626820A (en) 1979-08-10 1979-08-10 Immunosuppressing agent
US06/176,642 US4341774A (en) 1979-08-10 1980-08-11 Method for suppressing abnormal rise in immunological function and agent useful therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10121179A JPS5626820A (en) 1979-08-10 1979-08-10 Immunosuppressing agent

Publications (2)

Publication Number Publication Date
JPS5626820A JPS5626820A (en) 1981-03-16
JPS6365646B2 true JPS6365646B2 (enExample) 1988-12-16

Family

ID=14294571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10121179A Granted JPS5626820A (en) 1979-08-10 1979-08-10 Immunosuppressing agent

Country Status (2)

Country Link
US (1) US4341774A (enExample)
JP (1) JPS5626820A (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001899A1 (fr) * 1982-11-16 1984-05-24 Georges Motschan Nouvelle utilisation d'une vitamine unique ou d'une combinaison de diverses vitamines
US4801453A (en) * 1984-05-01 1989-01-31 James M. Broadbent Stabilized mussel extract
CA1272953A (en) 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
US4728643A (en) * 1984-11-02 1988-03-01 The General Hospital Corporation Method of treating psoriasis
GB2183156B (en) * 1985-03-14 1989-06-21 Chugai Pharmaceutical Co Ltd Composition for treating skin disease
US4749710A (en) * 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
GB8816505D0 (en) * 1988-07-12 1988-08-17 Leo Pharm Prod Ltd Novel treatment
CA2005227A1 (en) * 1988-12-14 1990-06-14 Choju Aoki Pharmaceutical preparation for chronic hepatitis treatment
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
US5753237A (en) * 1989-09-25 1998-05-19 University Of Utah Research Foundation Method for augmenting immunological responses
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6187764B1 (en) * 1997-05-05 2001-02-13 Angelina Pinal Buttz A and D vitamins and their metabolites: A new treatment for seasonal allergic rhinitis and atopy
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
US20010036937A1 (en) * 2000-04-07 2001-11-01 Leticia Delgado-Herrera Treatment of ICU-associated hypocalcemia with vitamin D compounds
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
CN103202821B (zh) * 2013-04-09 2014-10-01 青岛正大海尔制药有限公司 一种骨化三醇软胶囊及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639596A (en) * 1969-07-14 1972-02-01 Wisconsin Alumni Res Found Method of treating leg weakness in fowl with 25-hydroxycholecalciferol
US3739001A (en) * 1971-10-22 1973-06-12 Wisconsin Alumni Res Found 25,26-dihydroxycholecalciferol
US3741996A (en) * 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
US3715374A (en) * 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US3847955A (en) * 1973-07-16 1974-11-12 Wisconsin Alumni Res Found 1,24,25-trihydroxycholecalciferol
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
JPS5126858A (en) * 1974-08-22 1976-03-05 Teijin Ltd 24 * s * hidorokishikorekarushifuerooruno seizoho
JPS5126859A (en) * 1974-08-22 1976-03-05 Teijin Ltd 24 * r * hidorokishikorekarushifuerooruno seizoho
JPS51100056A (en) * 1975-02-28 1976-09-03 Chugai Pharmaceutical Co Ltd 1 arufua 255 jihidorokishikorekarushifuerooruno seiho
CA1077028A (en) * 1975-02-28 1980-05-06 Wisconsin Alumni Research Foundation PROCESS FOR PREPARATION OF 1.alpha.,2.alpha.-DIHYDROXY-CHOLECALCIFEROL
JPS5271456A (en) * 1975-12-12 1977-06-14 Chugai Pharmaceut Co Ltd Synthesis of 1alpha-hydroxysteroid derivatives
US4022768A (en) * 1976-02-12 1977-05-10 Wisconsin Alumni Research Foundation Process for preparation of 1α,25-dihydroxycholecalciferol
JPS603045B2 (ja) * 1976-04-19 1985-01-25 中外製薬株式会社 １α―ヒドロキシビタミンＤ類軟カプセルの製造方法
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds

Also Published As

Publication number Publication date
JPS5626820A (en) 1981-03-16
US4341774A (en) 1982-07-27

Similar Documents

Publication Publication Date Title
JPS6365646B2 (enExample)
Corrigan Jr et al. Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency
CA2406570C (en) Dermal compositions containing coenzyme q as the active ingredient
JPH0115484B2 (enExample)
Moon et al. Ninety-day oral toxicity study of rice-derived γ-oryzanol in Sprague-Dawley rats
JPS5832823A (ja) 脱癌剤
Weinstein et al. Effects of ethynyloestradiol on the metabolism of [1-14C]-oleate by perfused livers and hepatocytes from female rats
Doran et al. Rowachol--a possible treatment for cholesterol gallstones.
Doni et al. Glutathione peroxidase, selenium, and prostaglandin synthesis in platelets
Bacchus A quantitative abnormality in serum mucoproteins in the Marfan syndrome
Greenberg et al. Plasma cholesterol levels of cholesterol fed control and pyridoxine deficient monkeys.
EP0215956A1 (en) Composition for treating skin disease
Kim et al. Biochemical and physiological changes in the rat during riboflavin deprivation and supplementation
EP0896819A1 (en) Antiglucocorticoid drug
Carter et al. Effect of oral contraceptives on plasma clearance
Friedman et al. Effect of corticotropin upon triglyceride levels: Results in coronary-prone subjects and patients with Addison's disease
Lieske et al. Thymic carcinoid with cutaneous hyperpigmentation
Mackenzie et al. The effect of α-tocopherol, α-tocopherylhydroquinone and their esters on experimental muscular dystrophy in the rat
Berkowitz et al. Practical significance of serum triglycerides and radioactive fat tolerance: Their relation to current therapy for hypercholesterolemia
Wille et al. Demonstration of hyper‐α‐lipoproteinemia in three diabetic patients
JPH0399022A (ja) 骨代謝疾患治療剤及び骨代謝状態の評価方法
JPH0525049A (ja) 安定な１α―ヒドロキシビタミンＤ類製剤
Earll et al. Facial paralysis occurring with hypothyoidism. A report of two cases
JPS6341888B2 (enExample)
Rainer Membranes as Therapeutic Targets-Liposomes as Therapeutic Options.